EMSN:SIXEMS-CHEMIE HOLDING AG Analysis
Data as of 2026-03-11 - not real-time
CHF 611.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
EMS‑Chemie is trading in a narrow range just above its 20‑day moving average, with the 20‑day SMA comfortably above the 50‑day SMA, signalling a modest bullish bias. Revenue has slipped year‑over‑year while operating margins remain healthy, and the latest earnings release highlighted a margin‑driven profit increase but warned of further sales pressure from currency effects. The stock offers a dividend yield above two percent, yet the payout ratio approaches seventy percent and the company reports zero operating cash flow, raising questions about dividend sustainability. Valuation multiples such as price‑to‑earnings and price‑to‑book sit at the higher end of the sector spectrum, suggesting the market has priced in growth expectations that may be optimistic given the revenue decline. Technical indicators are mixed: the RSI sits near the midpoint, the MACD histogram is negative and the signal line is bearish, while volume trends are increasing, adding a layer of short‑term uncertainty. Overall, the picture is one of a fundamentally solid specialty‑chemicals player with attractive yield but constrained by cash generation and a challenging top‑line outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish SMA crossover supports limited upside
- Bearish MACD and mixed momentum increase downside risk
- Increasing volume suggests active trading but no clear breakout
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong operating margins offset revenue contraction
- Dividend yield attractive but cash flow constraints linger
- Currency headwinds could depress future sales
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Specialty‑chemical market fundamentals remain resilient
- Potential for margin‑driven earnings improvement
- Dividend provides income while the company works to restore cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth-7.30%
Profit Margin23.95%
P/E Ratio30.6
P/B Ratio6.9
Technical Analysis
TrendBullish
RSI44.5
SupportCHF 600.00
ResistanceCHF 646.00
MA 20CHF 626.80
MA 50CHF 608.48
MA 200CHF 594.14
MACDBearish
VolumeIncreasing
Fear & Greed Index76.09
Valuation
Target PriceCHF 625.71
Upside/Downside2.32%
GradeOvervalued
TypeValue
Dividend Yield2.25%
Risk Assessment
Beta0.11
Volatility19.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.